Cargando…
Genetic characterization and drug sensitivity study of newly derived HGBL double/triple-hit lymphoma cell lines
Autores principales: | Zhang, Jibin, Wang, Tingting, Shetty, Kunal, Alkan, Serhan, Xu, Senlin, Gong, Qiang, Liu, Xuxiang, Li, Yuping, Hu, Zunsong, Huang, Wendong, Wendel, Hans-Guido, Herrera, Alex F., Pillai, Raju K., Song, Joo Y., Chan, Wing C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9631616/ https://www.ncbi.nlm.nih.gov/pubmed/35687491 http://dx.doi.org/10.1182/bloodadvances.2021006709 |
Ejemplares similares
-
Molecularly Stratified Treatment Options in Primary Refractory DLBCL/HGBL with MYC and BCL2 or BCL6 Rearrangements (HGBL, NOS with MYC/BCL6)
por: Witte, Hanno M., et al.
Publicado: (2023) -
Triple hit effect
por: Dixit, Ramakant, et al.
Publicado: (2015) -
Targeting MYC and BCL2 by a natural compound for “double‐hit” lymphoma
por: Liu, Xiaoqian, et al.
Publicado: (2022) -
High-Grade B-Cell Lymphoma (HGBL) with MYC and BCL2 and/or BCL6 Rearrangements Is Predominantly BCL6-Rearranged and BCL6-Expressing in Taiwan
por: Tsai, Cheng-Chih, et al.
Publicado: (2021) -
Concepts of Double Hit and Triple Hit Disease in Multiple Myeloma, Entity and Prognostic Significance
por: Baysal, Mehmet, et al.
Publicado: (2020)